应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PSTX Poseida Therapeutics, Inc.
交易中 11-22 10:06:53 EST
2.77
+0.06
+2.03%
最高
2.78
最低
2.70
成交量
3.77万
今开
2.71
昨收
2.71
日振幅
2.95%
总市值
2.69亿
流通市值
1.79亿
总股本
9,747万
成交额
10.35万
换手率
0.06%
流通股本
6,470万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Poseida Therapeutics, Inc.盘中异动 股价大涨5.24%报2.81美元
市场透视 · 11-20 00:28
Poseida Therapeutics, Inc.盘中异动 股价大涨5.24%报2.81美元
Poseida Therapeutics, Inc.盘中异动 早盘股价大涨5.07%报2.90美元
市场透视 · 11-18
Poseida Therapeutics, Inc.盘中异动 早盘股价大涨5.07%报2.90美元
Poseida Therapeutics, Inc.2024财年第三财季实现净利润20.24百万美元,同比增加163.69%
市场透视 · 11-16
Poseida Therapeutics, Inc.2024财年第三财季实现净利润20.24百万美元,同比增加163.69%
Poseida Therapeutics, Inc.盘中异动 早盘快速拉升5.03%
市场透视 · 11-11
Poseida Therapeutics, Inc.盘中异动 早盘快速拉升5.03%
Poseida Therapeutics, Inc.股价拉升17.75% 市值涨5948.24万美元
市场透视 · 11-08
Poseida Therapeutics, Inc.股价拉升17.75% 市值涨5948.24万美元
Poseida Therapeutics, Inc.盘中异动 早盘大幅拉升5.26%
市场透视 · 11-06
Poseida Therapeutics, Inc.盘中异动 早盘大幅拉升5.26%
Poseida Therapeutics Inc 预计每股亏损 41 美分 - 财报前瞻
Reuters · 11-06
Poseida Therapeutics Inc 预计每股亏损 41 美分 - 财报前瞻
Poseida Therapeutics, Inc.盘中异动 大幅拉升5.26%报2.60美元
市场透视 · 11-05
Poseida Therapeutics, Inc.盘中异动 大幅拉升5.26%报2.60美元
Poseida Therapeutics, Inc.盘中异动 早盘股价大跌5.08%
市场透视 · 10-10
Poseida Therapeutics, Inc.盘中异动 早盘股价大跌5.08%
Poseida Therapeutics, Inc.盘中异动 早盘快速下跌5.12%报3.43美元
市场透视 · 09-20
Poseida Therapeutics, Inc.盘中异动 早盘快速下跌5.12%报3.43美元
Poseida Therapeutics, Inc.盘中异动 早盘急速下挫5.41%报2.80美元
自选股智能写手 · 08-20
Poseida Therapeutics, Inc.盘中异动 早盘急速下挫5.41%报2.80美元
Poseida Therapeutics, Inc.2024财年第二财季实现净利润-31.37百万美元,同比减少14.24%
自选股智能写手 · 08-17
Poseida Therapeutics, Inc.2024财年第二财季实现净利润-31.37百万美元,同比减少14.24%
Poseida Therapeutics, Inc.盘中异动 急速拉升5.32%
自选股智能写手 · 08-15
Poseida Therapeutics, Inc.盘中异动 急速拉升5.32%
Poseida Therapeutics, Inc.盘中异动 早盘快速下挫9.68%报2.80美元
自选股智能写手 · 08-05
Poseida Therapeutics, Inc.盘中异动 早盘快速下挫9.68%报2.80美元
Poseida Therapeutics Inc 预计每股亏损 41 美分 - 财报前瞻
Reuters · 08-02
Poseida Therapeutics Inc 预计每股亏损 41 美分 - 财报前瞻
Poseida Therapeutics, Inc.盘中异动 早盘股价大跌5.45%
自选股智能写手 · 07-31
Poseida Therapeutics, Inc.盘中异动 早盘股价大跌5.45%
Poseida Therapeutics, Inc.盘中异动 大幅上涨5.07%
自选股智能写手 · 07-23
Poseida Therapeutics, Inc.盘中异动 大幅上涨5.07%
Poseida Therapeutics, Inc.盘中异动 股价大涨5.30%
自选股智能写手 · 06-20
Poseida Therapeutics, Inc.盘中异动 股价大涨5.30%
Poseida Therapeutics, Inc.盘中异动 早盘股价大涨6.18%
自选股智能写手 · 06-12
Poseida Therapeutics, Inc.盘中异动 早盘股价大涨6.18%
Poseida Therapeutics, Inc.盘中异动 早盘快速下跌5.13%
自选股智能写手 · 06-06
Poseida Therapeutics, Inc.盘中异动 早盘快速下跌5.13%
加载更多
公司概况
公司名称:
Poseida Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Poseida Therapeutics, Inc.于2014年12月16日根据特拉华州法律注册成立。他们是一家临床阶段的生物制药公司,专注于利用其专有的下一代非病毒基因工程技术为患者创造有效的疗法。他们的专有基因工程技术用于创建主要由特定T细胞亚群,干细胞记忆或TSCM组成的候选产品,目的是弥补其他CAR-T疗法的局限性,包括治疗持续时间,治疗能力实体瘤和耐受性问题。他们相信,他们的管理团队在细胞和基因工程方面的经验将帮助他们快速发展,并希望获得将潜在的治疗性细胞和基因疗法商业化的批准。
发行价格:
--
{"stockData":{"symbol":"PSTX","market":"US","secType":"STK","nameCN":"Poseida Therapeutics, Inc.","latestPrice":2.765,"timestamp":1732287929013,"preClose":2.71,"halted":0,"volume":37705,"delay":0,"floatShares":64695752,"shares":97465024,"eps":-0.635371,"marketStatus":"交易中","marketStatusCode":2,"change":0.055,"latestTime":"11-22 10:06:53 EST","open":2.71,"high":2.78,"low":2.7,"amount":103462.4031145,"amplitude":0.02952,"askPrice":2.78,"askSize":700,"bidPrice":2.76,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.635371,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1594353600000,"adjPreClose":2.71,"preHourTrading":{"tag":"盘前","latestPrice":2.7,"preClose":2.71,"latestTime":"09:26 EST","volume":254,"amount":685.8000000000001,"timestamp":1732285590044},"postHourTrading":{"tag":"盘后","latestPrice":2.71,"preClose":2.71,"latestTime":"16:20 EST","volume":1347,"amount":3650.37,"timestamp":1732224041826},"volumeRatio":0.907886,"impliedVol":0.0158,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/PSTX","defaultTab":"news","newsList":[{"id":"2484922194","title":"Poseida Therapeutics, Inc.盘中异动 股价大涨5.24%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484922194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484922194?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:28","pubTimestamp":1732033725,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时28分,Poseida Therapeutics, Inc.股票出现波动,股价快速上涨5.24%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.89%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000284598e438d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000284598e438d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2484676732","title":"Poseida Therapeutics, Inc.盘中异动 早盘股价大涨5.07%报2.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676732?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:36","pubTimestamp":1731940561,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时36分,Poseida Therapeutics, Inc.股票出现异动,股价大幅拉升5.07%。截至发稿,该股报2.90美元/股,成交量3.2531万股,换手率0.03%,振幅7.97%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360195be48af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360195be48af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTX","BK4139"],"gpt_icon":0},{"id":"2483306744","title":"Poseida Therapeutics, Inc.2024财年第三财季实现净利润20.24百万美元,同比增加163.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306744?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686436,"startTime":"0","endTime":"0","summary":"11月16日,Poseida Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为20.24百万美元,同比增加163.69%;其中营业收入为71.75百万美元,同比增加667.38%,每股基本收益为0.21美元。从资产负债表来看,Poseida Therapeutics, Inc.总负债2.06亿美元,其中短期债务6.09百万美元,资产负债比为1.43,流动比率为0.04。机构评级:截至2024年11月16日,当前有3家机构对Poseida Therapeutics, Inc.目标价做出预测,其中目标均价为14.00美元,其中最低目标价为10.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000328abc51617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000328abc51617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","LENZ"],"gpt_icon":0},{"id":"2482738245","title":"Poseida Therapeutics, Inc.盘中异动 早盘快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738245?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:32","pubTimestamp":1731335530,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时32分,Poseida Therapeutics, Inc.股票出现异动,股价急速拉升5.03%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223210abb66194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223210abb66194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PSTX"],"gpt_icon":0},{"id":"2481101029","title":"Poseida Therapeutics, Inc.股价拉升17.75% 市值涨5948.24万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101029?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076355,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分,Poseida Therapeutics, Inc.股票出现异动,股价大幅上涨17.75%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822323595bdef25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822323595bdef25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTX","BK4139"],"gpt_icon":0},{"id":"2481985486","title":"Poseida Therapeutics, Inc.盘中异动 早盘大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985486?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:34","pubTimestamp":1730903676,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时34分,Poseida Therapeutics, Inc.股票出现波动,股价急速拉升5.26%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223436971a4c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223436971a4c3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2481178604","title":"Poseida Therapeutics Inc 预计每股亏损 41 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481178604","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481178604?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:49","pubTimestamp":1730900975,"startTime":"0","endTime":"0","summary":" * Poseida Therapeutics Inc 预计将在11月7日公布截至0001年1月1日的业绩报告(预计),季度收入将有所增长。* LSEG 分析师对 Poseida Therapeutics Inc 的平均预期是每股亏损 41 美分。* 华尔街对 Poseida Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元,高于其上一次收盘价 2.66 美元。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PSTX"],"gpt_icon":0},{"id":"2481919536","title":"Poseida Therapeutics, Inc.盘中异动 大幅拉升5.26%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481919536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481919536?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:36","pubTimestamp":1730738201,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时36分,Poseida Therapeutics, Inc.股票出现波动,股价急速拉升5.26%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003642971a4378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003642971a4378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTX","LENZ"],"gpt_icon":0},{"id":"2474746928","title":"Poseida Therapeutics, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474746928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474746928?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:31","pubTimestamp":1728567097,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时31分,Poseida Therapeutics, Inc.股票出现波动,股价快速下挫5.08%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102131379719f809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102131379719f809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTX","BK4139"],"gpt_icon":0},{"id":"2468562092","title":"Poseida Therapeutics, Inc.盘中异动 早盘快速下跌5.12%报3.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468562092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468562092?lang=zh_cn&edition=full","pubTime":"2024-09-20 23:08","pubTimestamp":1726844915,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日23时08分,Poseida Therapeutics, Inc.股票出现波动,股价急速下跌5.12%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.25%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920230836ab64e770&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920230836ab64e770&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTX","LENZ"],"gpt_icon":0},{"id":"2460007145","title":"Poseida Therapeutics, Inc.盘中异动 早盘急速下挫5.41%报2.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460007145","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460007145?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:03","pubTimestamp":1724162589,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时03分,Poseida Therapeutics, Inc.股票出现异动,股价急速下跌5.41%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820220309971994f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820220309971994f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2460902249","title":"Poseida Therapeutics, Inc.2024财年第二财季实现净利润-31.37百万美元,同比减少14.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460902249","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460902249?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824033,"startTime":"0","endTime":"0","summary":"8月17日,Poseida Therapeutics, Inc.公布财报,公告显示公司2024财年第二财季净利润为-31.37百万美元,同比减少14.24%;其中营业收入为25.97百万美元,同比增加29.79%,每股基本收益为-0.32美元。从资产负债表来看,Poseida Therapeutics, Inc.总负债2.38亿美元,其中短期债务6.04百万美元,资产负债比为1.26,流动比率为2.50。机构评级:截至2024年8月17日,当前有3家机构对Poseida Therapeutics, Inc.目标价做出预测,其中目标均价为14.00美元,其中最低目标价为10.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005269f31b088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005269f31b088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","LENZ"],"gpt_icon":0},{"id":"2459479141","title":"Poseida Therapeutics, Inc.盘中异动 急速拉升5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459479141","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459479141?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:04","pubTimestamp":1723734273,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时04分,Poseida Therapeutics, Inc.股票出现异动,股价急速拉升5.32%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523043397198d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523043397198d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2457677882","title":"Poseida Therapeutics, Inc.盘中异动 早盘快速下挫9.68%报2.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457677882","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457677882?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864770,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分,Poseida Therapeutics, Inc.股票出现波动,股价急速下挫9.68%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.36%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213250957f2e72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213250957f2e72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PSTX"],"gpt_icon":0},{"id":"2456283529","title":"Poseida Therapeutics Inc 预计每股亏损 41 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456283529","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456283529?lang=zh_cn&edition=full","pubTime":"2024-08-02 20:45","pubTimestamp":1722602753,"startTime":"0","endTime":"0","summary":" * Poseida Therapeutics Inc 预计将在8月6日公布截至2024年6月30日的业绩(估计),季度收入将出现下降。* LSEG 分析师对 Poseida Therapeutics Inc 的平均预期是每股亏损 41 美分。* 华尔街对 Poseida Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元,高于其上一次收盘价 3.32 美元。8月2日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSTX","LENZ"],"gpt_icon":0},{"id":"2455158126","title":"Poseida Therapeutics, Inc.盘中异动 早盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455158126","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455158126?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:36","pubTimestamp":1722436588,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日22时36分,Poseida Therapeutics, Inc.股票出现异动,股价快速下挫5.45%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731223628af9525b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731223628af9525b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2453563714","title":"Poseida Therapeutics, Inc.盘中异动 大幅上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453563714","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453563714?lang=zh_cn&edition=full","pubTime":"2024-07-23 02:55","pubTimestamp":1721674521,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日02时55分,Poseida Therapeutics, Inc.股票出现异动,股价急速拉升5.07%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.94%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230255219681ef15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230255219681ef15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2444217445","title":"Poseida Therapeutics, Inc.盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444217445","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444217445?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:55","pubTimestamp":1718891736,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时55分,Poseida Therapeutics, Inc.股票出现异动,股价大幅上涨5.30%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620215536aef5daf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620215536aef5daf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTX","BK4139"],"gpt_icon":0},{"id":"2442552457","title":"Poseida Therapeutics, Inc.盘中异动 早盘股价大涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552457","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442552457?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199090,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分,Poseida Therapeutics, Inc.股票出现波动,股价大幅上涨6.18%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213130af8d2f8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213130af8d2f8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PSTX"],"gpt_icon":0},{"id":"2441743171","title":"Poseida Therapeutics, Inc.盘中异动 早盘快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441743171","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441743171?lang=zh_cn&edition=full","pubTime":"2024-06-06 22:27","pubTimestamp":1717684039,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日22时27分,Poseida Therapeutics, Inc.股票出现波动,股价快速跳水5.13%。Poseida Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。Poseida Therapeutics, Inc.公司简介:Poseida Therapeutics Inc是一家临床阶段的生物制药公司,致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606222720968129f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606222720968129f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTX","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.poseida.com","stockEarnings":[{"period":"1week","weight":-0.1558},{"period":"1month","weight":0.084},{"period":"3month","weight":-0.0524},{"period":"6month","weight":-0.0875},{"period":"1year","weight":0.0383},{"period":"ytd","weight":-0.1935}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Poseida Therapeutics, Inc.于2014年12月16日根据特拉华州法律注册成立。他们是一家临床阶段的生物制药公司,专注于利用其专有的下一代非病毒基因工程技术为患者创造有效的疗法。他们的专有基因工程技术用于创建主要由特定T细胞亚群,干细胞记忆或TSCM组成的候选产品,目的是弥补其他CAR-T疗法的局限性,包括治疗持续时间,治疗能力实体瘤和耐受性问题。他们相信,他们的管理团队在细胞和基因工程方面的经验将帮助他们快速发展,并希望获得将潜在的治疗性细胞和基因疗法商业化的批准。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.043102},{"month":2,"riseRate":0.5,"avgChangeRate":0.00152},{"month":3,"riseRate":0.25,"avgChangeRate":-0.140178},{"month":4,"riseRate":0,"avgChangeRate":-0.1786},{"month":5,"riseRate":0.25,"avgChangeRate":-0.066802},{"month":6,"riseRate":0.5,"avgChangeRate":0.01857},{"month":7,"riseRate":0.25,"avgChangeRate":-0.008411},{"month":8,"riseRate":0.6,"avgChangeRate":0.027276},{"month":9,"riseRate":0.4,"avgChangeRate":-0.001281},{"month":10,"riseRate":0.4,"avgChangeRate":0.003161},{"month":11,"riseRate":1,"avgChangeRate":0.134074},{"month":12,"riseRate":0.5,"avgChangeRate":0.08636}],"exchange":"NASDAQ","name":"Poseida Therapeutics, Inc.","nameEN":"Poseida Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Poseida Therapeutics, Inc.(PSTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Poseida Therapeutics, Inc.(PSTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Poseida Therapeutics, Inc.,PSTX,Poseida Therapeutics, Inc.股票,Poseida Therapeutics, Inc.股票老虎,Poseida Therapeutics, Inc.股票老虎国际,Poseida Therapeutics, Inc.行情,Poseida Therapeutics, Inc.股票行情,Poseida Therapeutics, Inc.股价,Poseida Therapeutics, Inc.股市,Poseida Therapeutics, Inc.股票价格,Poseida Therapeutics, Inc.股票交易,Poseida Therapeutics, Inc.股票购买,Poseida Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Poseida Therapeutics, Inc.(PSTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Poseida Therapeutics, Inc.(PSTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}